Last reviewed · How we verify
Placebo Tablet: BID — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Tablet: BID (Placebo Tablet: BID) — Otsuka Pharmaceutical Development & Commercialization, Inc.. Placebo has no active pharmacological mechanism; it is an inert substance used as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Tablet: BID TARGET | Placebo Tablet: BID | Otsuka Pharmaceutical Development & Commercialization, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Tablet: BID CI watch — RSS
- Placebo Tablet: BID CI watch — Atom
- Placebo Tablet: BID CI watch — JSON
- Placebo Tablet: BID alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Tablet: BID — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-tablet-bid. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing